Cornerstone Advisors LLC cut its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 99.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,773 shares of the company’s stock after selling 581,958 shares during the quarter. Cornerstone Advisors LLC’s holdings in BlackRock Health Sciences Term Trust were worth $29,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Karpus Management Inc. increased its position in shares of BlackRock Health Sciences Term Trust by 27.1% in the 4th quarter. Karpus Management Inc. now owns 1,217,589 shares of the company’s stock valued at $17,838,000 after purchasing an additional 259,464 shares during the last quarter. Wolverine Asset Management LLC increased its position in shares of BlackRock Health Sciences Term Trust by 260.3% in the 4th quarter. Wolverine Asset Management LLC now owns 274,318 shares of the company’s stock valued at $4,019,000 after purchasing an additional 198,177 shares during the last quarter. Weiss Asset Management LP purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at approximately $2,669,000. Quantedge Capital Pte Ltd increased its position in shares of BlackRock Health Sciences Term Trust by 47.5% in the 4th quarter. Quantedge Capital Pte Ltd now owns 375,026 shares of the company’s stock valued at $5,494,000 after purchasing an additional 120,800 shares during the last quarter. Finally, LM Advisors LLC purchased a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at $1,591,000.
BlackRock Health Sciences Term Trust Trading Up 0.7 %
Shares of NYSE BMEZ traded up 0.11 during mid-day trading on Friday, reaching 15.70. The company had a trading volume of 1,264,400 shares, compared to its average volume of 302,977. The firm has a 50 day simple moving average of 15.29 and a two-hundred day simple moving average of 15.47. BlackRock Health Sciences Term Trust has a 52-week low of 12.93 and a 52-week high of 16.59.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Overbought Stocks Explained: Should You Trade Them?
- Why This AI Stock is Rising Despite Tech Sell-Off
- What is the Nikkei 225 index?
- MarketBeat Week in Review – 7/15 – 7/19
- Investing in the High PE Growth Stocks
- Investors Are Moving into Bonds and Small Cap Stocks: Here’s Why
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.